Literature DB >> 3240725

Effects of ketanserin on systemic and regional haemodynamics in patients with essential hypertension.

Y Ito1, M Isaka, H Noda, Y Sato, T Fujita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3240725     DOI： 10.2165/00003495-198800361-00023

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  11 in total

Review 1.  Antihypertensive mode of action of ketanserin.

Authors:  J I Robertson; D J Stott; S G Ball
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105

2.  The role of renal hemodynamics in the antihypertensive effect of captopril.

Authors:  K Ando; T Fujita; Y Ito; H Noda; K Yamashita
Journal:  Am Heart J       Date:  1986-02       Impact factor: 4.749

3.  Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.

Authors:  G J Wenting; A J Man in 't Veld; A J Woittiez; F Boomsma; M A Schalekamp
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

4.  Vasodilatory actions of alpha-human atrial natriuretic peptide and high Ca2+ effects in normal man.

Authors:  T Fujita; Y Ito; H Noda; Y Sato; K Ando; K Kangawa; H Matsuo
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 5.  Antihypertensive properties of ketanserin (R 41 468).

Authors:  P M Vanhoutte; J M Van Nueten; J Symoens; P A Janssen
Journal:  Fed Proc       Date:  1983-02

6.  5-hydroxytryptamine and vascular disease.

Authors:  P M Vanhoutte
Journal:  Fed Proc       Date:  1983-02

7.  Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension.

Authors:  R Fagard; R Fiocchi; P Lijnen; J Staessen; E Moerman; A de Schaepdryver; A Amery
Journal:  Br Heart J       Date:  1984-02

8.  Chronic effect of ketanserin in mild to moderate essential hypertension.

Authors:  A J Woittiez; G J Wenting; A H van den Meiracker; H J Ritsema van Eck; A J Man in't Veld; F A Zantvoort; M A Schalekamp
Journal:  Hypertension       Date:  1986-02       Impact factor: 10.190

9.  5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.

Authors:  G J Wenting; A J Woittiez; A J Man in't Veld; M A Schalekamp
Journal:  Hypertension       Date:  1984 Jan-Feb       Impact factor: 10.190

10.  Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.

Authors:  T Fujita; K Ando; H Noda; Y Sato; N Yamashita; K Yamashita
Journal:  Am J Med       Date:  1982-09       Impact factor: 4.965
View more
  1 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.